TW200738283A - Formulations of conjugated estrogens and bazedoxifene - Google Patents

Formulations of conjugated estrogens and bazedoxifene

Info

Publication number
TW200738283A
TW200738283A TW095123252A TW95123252A TW200738283A TW 200738283 A TW200738283 A TW 200738283A TW 095123252 A TW095123252 A TW 095123252A TW 95123252 A TW95123252 A TW 95123252A TW 200738283 A TW200738283 A TW 200738283A
Authority
TW
Taiwan
Prior art keywords
bazedoxifene
conjugated estrogens
formulations
salt
estrogens
Prior art date
Application number
TW095123252A
Other languages
English (en)
Inventor
Ramarao S Chatlapalli
Arwinder Nagi
Pelt Lawrence Van
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37401610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200738283(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of TW200738283A publication Critical patent/TW200738283A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
TW095123252A 2005-06-29 2006-06-28 Formulations of conjugated estrogens and bazedoxifene TW200738283A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69488905P 2005-06-29 2005-06-29

Publications (1)

Publication Number Publication Date
TW200738283A true TW200738283A (en) 2007-10-16

Family

ID=37401610

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095123252A TW200738283A (en) 2005-06-29 2006-06-28 Formulations of conjugated estrogens and bazedoxifene

Country Status (19)

Country Link
US (1) US20070003623A1 (zh)
EP (1) EP1898888A2 (zh)
JP (1) JP2008545012A (zh)
KR (1) KR20080031037A (zh)
CN (1) CN101252921A (zh)
AR (1) AR054806A1 (zh)
AU (1) AU2006263638A1 (zh)
BR (1) BRPI0612586A2 (zh)
CA (1) CA2613102A1 (zh)
CR (1) CR9597A (zh)
EC (1) ECSP078057A (zh)
IL (1) IL188223A0 (zh)
NI (1) NI200700331A (zh)
NO (1) NO20080002L (zh)
PA (1) PA8684501A1 (zh)
PE (1) PE20070188A1 (zh)
RU (1) RU2395286C2 (zh)
TW (1) TW200738283A (zh)
WO (1) WO2007002823A2 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1942177B (zh) * 2004-04-08 2011-05-25 惠氏公司 醋酸巴泽多昔芬固体分散剂型
CL2007003429A1 (es) * 2006-11-29 2008-04-11 Wyeth Corp Tableta bi-capa que comprende una primera capa con al menos un estrogeno y una segunda capa con uno o mas agentes terapeuticos seleccionados entre un modulador selectivo del receptor de estrogeno y un agente progestacional; proceso de produccion, uti
CN101631536A (zh) * 2007-01-12 2010-01-20 惠氏公司 片中片组合物
PE20090100A1 (es) * 2007-03-30 2009-02-26 Wyeth Corp Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
WO2011056532A2 (en) * 2009-10-27 2011-05-12 Wyeth Llc Bazedoxifene formulations with antioxidants
KR20130076818A (ko) * 2010-04-20 2013-07-08 시플라 리미티드 약학 조성물
CN103119878B (zh) * 2010-07-29 2016-11-16 熵通信有限公司 用于消除交叉极化干扰和交叉卫星干扰的方法和装置
SG10201606751XA (en) * 2011-05-13 2016-10-28 Eb Ip Hybritabs B V Drug Delivery System
CN104013630B (zh) * 2014-05-23 2018-08-21 合肥九研医药科技开发有限公司 一种复方醋酸巴多昔芬雌激素组合物
DK3310333T3 (da) 2015-06-18 2020-06-02 Estetra Sprl Oralt dispergibel doseringsenhed indeholdende en estetrolkomponent
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
WO2018182205A1 (ko) * 2017-03-30 2018-10-04 한미약품 주식회사 바제독시펜 아세테이트를 함유하는 안정화된 약제학적 조성물
JOP20200260A1 (ar) * 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) * 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) * 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US6479535B1 (en) * 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
DE60043305D1 (de) * 1999-07-06 2009-12-24 Endorech Inc Pharmazeutische zubereitungen zur behandlung von insulinresitenz
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
NZ537051A (en) * 2002-06-13 2007-11-30 Wyeth Corp Use of bazedoxifene in an extended dosage treatment regimen
PE20060173A1 (es) * 2004-04-07 2006-04-12 Wyeth Corp Polimorfo cristalino de acetato de bazedoxifeno
PA8629101A1 (es) * 2004-04-07 2005-11-25 Wyeth Corp Polimorfo cristalino de acetato de bazedoxifeno
CN1942177B (zh) * 2004-04-08 2011-05-25 惠氏公司 醋酸巴泽多昔芬固体分散剂型
RU2006132181A (ru) * 2004-04-08 2008-05-20 Вайет (Us) Базедоксифен аскорбат в качестве селективного модулятора рецептора эстрогена

Also Published As

Publication number Publication date
PA8684501A1 (es) 2007-01-17
RU2395286C2 (ru) 2010-07-27
AR054806A1 (es) 2007-07-18
JP2008545012A (ja) 2008-12-11
RU2007148071A (ru) 2009-08-10
EP1898888A2 (en) 2008-03-19
CN101252921A (zh) 2008-08-27
ECSP078057A (es) 2008-01-23
IL188223A0 (en) 2008-03-20
NI200700331A (es) 2009-02-16
NO20080002L (no) 2008-03-12
AU2006263638A1 (en) 2007-01-04
US20070003623A1 (en) 2007-01-04
CA2613102A1 (en) 2007-01-04
WO2007002823A3 (en) 2007-08-09
PE20070188A1 (es) 2007-03-16
CR9597A (es) 2008-03-06
WO2007002823A2 (en) 2007-01-04
BRPI0612586A2 (pt) 2010-11-23
KR20080031037A (ko) 2008-04-07

Similar Documents

Publication Publication Date Title
TW200738283A (en) Formulations of conjugated estrogens and bazedoxifene
IL154981A0 (en) Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents
TW200700406A (en) Novel thiophene derivatives
TW200716591A (en) Novel thiophene derivatives
TW200708511A (en) Novel thiophene derivatives
IL183102A0 (en) Betulin derivatives and pharmaceutical compositions containing the same
TW200716552A (en) Novel thiophene derivatives
MY154909A (en) Novel thiophene derivatives
TW200738670A (en) Novel thiophene derivatives
EP1708719A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITIONS OF 2,6-DIISOPROPYLPHENOL (PROPOFOL) AND THEIR USE
TW200800967A (en) Benzimidazole thiophene compounds
IL177744A0 (en) Aptamers and pharmaceutical compositions containing the same
IL183044A0 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
ZA200706160B (en) Pharmaceutically active phosphate binders, their manufactue, compositions containing them and their use
TW200719881A (en) Sedative effect-enabling agent and sedative aroma composition comprising the same
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
PL2142174T3 (pl) Stabilne wodne preparaty G-CSF
PL1677818T3 (pl) Stabilne kompozycje wodne zawierające G-CSF
MXPA05008902A (es) Soluciones de drogas en mentol.
TNSN07241A1 (en) Substituted pyrroles, compositions containing same, method for making same and use thereof
EP1797078A4 (en) BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THESE DERIVATIVES, PREPARATION AND USES THEREOF
IL190063A (en) The history of cycloalkanes is preserved, their medicinal preparations and their uses
EP1797077A4 (en) BENZIMIDAZOLE DERIVATIVES, COMPOSITIONS CONTAINING THEM, PREPARATION THEREOF AND APPLICATIONS THEREOF
HK1142880A1 (zh) -十碳三烯- -醇及香料組合物
TW200505460A (en) Rosmarinic acid composition